MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC).

被引：0
|
作者：
Mehdi, Maahum
Thalji, Samih Z.
Shreenivas, Aditya V.
Chakrabarti, Sakti
Thomas, James P.
Christians, Kathleen K.
Evans, Douglas B.
Hall, William A.
Erickson, Beth
Thapa, Bicky
Ahmed, Gulrayz
Yazdanpanah, Omid
Kurzrock, Razelle
Aldakkak, Mohammed
Holden, Mary Beth
Ben George
Tsai, Susan
Oxencis, Carolyn
McFall, Thomas
Kamgar, Mandana
机构：
[1] Med Coll Wisconsin, Wauwatosa, WI USA
[2] Med Coll Wisconsin, Milwaukee, WI USA
[3] Mayo Clin, Rochester, MN USA
[4] Cleveland Clin, Dept Med, Cleveland, OH USA
[5] Wayne State Univ, Detroit, MI USA
[6] Wisconsin Canc Ctr, Med Coll, Milwaukee, WI USA
[7] Med Coll Wisconsin, Dept Surg, Milwaukee, WI USA
[8] Med Coll Wisconsin, 8701W Watertown Plank Rd, Milwaukee, WI USA
[9] Froedtert & Med Coll Wisconsin, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16260
引用
收藏
页码：E16260 / E16260
页数：1
相关论文
共 50 条
  • [1] Trametinib and Hydroxychloroquine (HCQ) Combination Treatment in KRAS-Mutated Advanced Pancreatic Adenocarcinoma: Detailed Description of Two Cases
    Xavier, Camila B.
    Marchetti, Katia R.
    Castria, Tiago B.
    Jardim, Denis L. F.
    Fernandes, Gustavo S.
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (01) : 374 - 380
  • [2] Trametinib and Hydroxychloroquine (HCQ) Combination Treatment in KRAS-Mutated Advanced Pancreatic Adenocarcinoma: Detailed Description of Two Cases
    Camila B. Xavier
    Katia R. Marchetti
    Tiago B. Castria
    Denis L. F. Jardim
    Gustavo S. Fernandes
    Journal of Gastrointestinal Cancer, 2021, 52 : 374 - 380
  • [3] Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Kamgar, Mandana
    George, Ben
    Szabo, Aniko
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William Adrian
    Erickson, Beth
    Ahmed, Gulrayz
    Thapa, Bicky
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
    Babiker, Hani M.
    Karass, Michael
    Recio-Boiles, Alejandro
    Chandana, Sreenivasa R.
    McBride, Ali
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 583 - 592
  • [6] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [7] Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C) and hydroxychloroquine (HCQ) neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC).
    Borazanci, Erkut Hasan
    Jameson, Gayle S.
    Snyder, Courtney Edwards
    Thosani, Amar
    Sckolnik, Steven
    Korn, Ronald Lee
    Rahmanuddin, Syed
    Mocan, Dan
    Pearse, Shelby
    Gordon, Michael S.
    Von Hoff, Daniel D.
    Modasi, Aryan
    Amini, Albert
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 667 - 667
  • [8] Therapeutic benefit of targeting ERK in mutant KRAS in pancreatic ductal adenocarcinoma (PDAC)
    Hayes, Tikvah K.
    Neel, Nicole F.
    Chenard, Melissa
    Yeh, Jen Jen
    Samatar, Ahmed
    Der, Channing J.
    CANCER RESEARCH, 2013, 73
  • [9] Molecular and clinical characteristics of patients with KRAS mutated pancreatic ductal adenocarcinoma
    Xiao, Alexander Hua
    Desai, Aakash
    Halfdanarson, Thorvardur Ragnar
    Alberts, Steven R.
    McWilliams, Robert R.
    Mahipal, Amit
    Bekaii-Saab, Tanios S.
    Shi, Qian
    Carr, Ryan Michael
    Ma, Wen Wee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Genomic characterization of ATM alterations in advanced pancreatic ductal adenocarcinoma (PDAC).
    Perera, Sheron
    Denroche, Robert Edward
    Holter, Spring
    Kelly, Deirdre
    Zhang, Amy
    Wang Yifan
    Dodd, Anna
    Ramotar, Stephanie
    Hutchinson, Shawn
    Tehfe, Mustapha
    Ramjeesingh, Ravi
    Biagi, James Joseph
    Wilson, Julie
    Notta, Faiyaz
    Fischer, Sandra
    Zogopoulos, George
    Grant, Robert C.
    Gallinger, Steven
    Knox, Jennifer J.
    O'Kane, Grainne M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
12345